Details

Autor(en) / Beteiligte

• Gieras, Anna, MSc
• Focke-Tejkl, Margarete, PhD
• Ball, Tanja, PhD
• Verdino, Petra, PhD
• Hartl, Arnulf, PhD
• Thalhamer, Josef, PhD
• Valenta, Rudolf, MD

Titel

Molecular determinants of allergen-induced effector cell degranulation

Ist Teil von

• Journal of Allergy and Clinical Immunology, 2007-02, Vol.119 (2), p.384-390

Ort / Verlag

New York, NY: Mosby, Inc

Erscheinungsjahr

2007

Link zum Volltext

Quelle

Wiley Online Library Journals Frontfile Complete

Beschreibungen/Notizen

• Background Allergen-induced effector cell degranulation is a key event in allergic inflammation and leads to early-phase symptoms, such as allergic rhinitis, conjunctivitis, urticaria, or bronchial asthma. Objective We sought to study molecular determinants of effector cell degranulation using a monoclonal IgE antibody specific for a peptide epitope of one of the most important respiratory allergens, the major grass pollen allergen Phl p 1, as a model system. Methods A hybridoma cell line producing a monoclonal IgE antibody against a Phl p 1–derived peptide, P1, was established by means of immunization of mice and used to sensitize rat basophil leukemia cells, which were exposed to P1 monomer, P1 dimer, and P1 polymer. Results It is demonstrated that the number of IgE epitopes on an allergen molecule and the concentration of allergen-specific IgE antibodies determine the extent of degranulation. The P1 monomer did not cause mediator release and prevented degranulation induced by polymeric P1. Conclusion Our results suggest that the number of IgE epitopes on an allergen molecule determines its allergenic activity and explains why increases of allergen-specific IgE levels make patients more sensitive to allergens. Allergen-derived monomeric structures isolated by means of combinatorial chemistry might be used to develop new therapeutic strategies for allergy. Clinical implications Our study reveals molecular factors that determine the immediate allergenic activity of allergens and hence influence clinical sensitivity to these allergens.